Qiulan Ding
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Qiulan Ding has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
Xuefeng Wang
Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; and
8 shared publicationsJing Dai
Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
4 shared publications- Qihua Fu
Pediatric Translational Medicine Institute, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
4 shared publications Wenman Wu
Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
4 shared publications- Xuefeng Wang
Hoxworth Center, College of Medicine, University of Cincinnati
4 shared publications Changming Chen
Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3 shared publications
Latest Publications
- 23 June 2026
- Published by Elsevier in Thrombosis Research
- Vol. 263, 109762
Molecular basis of the E69Q and R383W heterozygous F2 variants identified in the proband associated with severe hemostatic defects
- 23 June 2026
- Published by Elsevier in Thrombosis Research
- Vol. 263, 109762
Molecular basis of the E69Q and R383W heterozygous F2 variants identified in the proband associated with severe hemostatic defects
- 14 April 2026
- Published by Elsevier in Thrombosis Research
- Vol. 261, 109682
Pseudoexon inclusion induced by three deep intronic variants in hemophilia B and correction achieved through an antisense oligonucleotide-based strategy
- 14 April 2026
- Published by Elsevier in Thrombosis Research
- Vol. 261, 109682
Pseudoexon inclusion induced by three deep intronic variants in hemophilia B and correction achieved through an antisense oligonucleotide-based strategy
- 4 January 2024
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 22 (4) , 975-989
Pleiotropic effects of different exonic nucleotide changes at the same position contribute to hemophilia B phenotypic variation
- 4 January 2024
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 22 (4) , 975-989
Pleiotropic effects of different exonic nucleotide changes at the same position contribute to hemophilia B phenotypic variation
- 26 December 2023
- Published by Elsevier in Thrombosis Research
- Vol. 234, 39-50
A novel GATA1 variant p.G229D causing the defect of procoagulant platelet formation
- 26 December 2023
- Published by Elsevier in Thrombosis Research
- Vol. 234, 39-50
A novel GATA1 variant p.G229D causing the defect of procoagulant platelet formation
- Open Access
- 27 November 2023
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 124 (04) , 374-385
Complete F9 Gene Deletion, Duplication, and Triplication Rearrangements: Implications for Factor IX Expression and Clinical Phenotypes
Background Factor IX (FIX) plays a critical role in blood coagulation. Complete deletion of F9 results in severe hemophilia B, whereas the clinical implications of complete F9 duplication and triplication remain understudied. Objective To investigate the rearrangement mechanisms underlying complete F9 deletion (cases 1 and 2), duplication (cases 3 and 4), and triplication (case 5), and to explore their association with FIX expression levels and clinical impacts. Methods Plasma FIX levels were detected using antigen and activity assays. CNVplex technology, optical genome mapping, and long-distance polymerase chain reaction were employed to characterize the breakpoints of the chromosomal rearrangements. Results Cases 1 and 2 exhibited FIX activities below 1%. Case 3 displayed FIX activities within the reference range. However, cases 4 and 5 showed a significant increase in FIX activities. Alu-mediated nonallelic homologous recombination was identified as the cause of F9 deletion in case 1; FoSTeS/MMBIR (Fork Stalling and Template Switching/microhomology-mediated break-induced replication) contributed to both F9 deletion and tandem duplication observed in cases 2 and 3; BIR/MMBIR (break-induced replication/microhomology-mediated break-induced replication) mediated by the same pair of low-copy repeats results in similar duplication–triplication/inversion–duplication (DUP–TRP/INV–DUP) rearrangements in cases 4 and 5, leading to complete F9 duplication and triplication, respectively. Conclusion Large deletions involving the F9 gene exhibit no apparent pattern, and the extra-hematologic clinical phenotypes require careful analysis of other genes within the deletion. The impact of complete F9 duplication and triplication on FIX expression might depend on the integrity of the F9 upstream sequence and the specific rearrangement mechanisms. Notably, DUP–TRP/INV–DUP rearrangements significantly elevate FIX activity and are closely associated with thrombotic phenotypes. Y.M. and Y.L. designed and performed the experiments and contributed to the writing of the manuscript. J.S., Q.L., and R.W., collected and organized the clinical cases. Q.D. and J.D. analyzed the data, reviewed and revised the manuscript, and provided supervision for the entire project. * These authors contributed equally as co-first authors. Received: 08 September 2023 Accepted: 21 November 2023 Accepted Manuscript online: 27 November 2023 Article published online: 26 December 2023 © 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 27 November 2023
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 124 (04) , 374-385
Open AccessComplete F9 Gene Deletion, Duplication, and Triplication Rearrangements: Implications for Factor IX Expression and Clinical Phenotypes
Background Factor IX (FIX) plays a critical role in blood coagulation. Complete deletion of F9 results in severe hemophilia B, whereas the clinical implications of complete F9 duplication and triplication remain understudied. Objective To investigate the rearrangement mechanisms underlying complete F9 deletion (cases 1 and 2), duplication (cases 3 and 4), and triplication (case 5), and to explore their association with FIX expression levels and clinical impacts. Methods Plasma FIX levels were detected using antigen and activity assays. CNVplex technology, optical genome mapping, and long-distance polymerase chain reaction were employed to characterize the breakpoints of the chromosomal rearrangements. Results Cases 1 and 2 exhibited FIX activities below 1%. Case 3 displayed FIX activities within the reference range. However, cases 4 and 5 showed a significant increase in FIX activities. Alu-mediated nonallelic homologous recombination was identified as the cause of F9 deletion in case 1; FoSTeS/MMBIR (Fork Stalling and Template Switching/microhomology-mediated break-induced replication) contributed to both F9 deletion and tandem duplication observed in cases 2 and 3; BIR/MMBIR (break-induced replication/microhomology-mediated break-induced replication) mediated by the same pair of low-copy repeats results in similar duplication–triplication/inversion–duplication (DUP–TRP/INV–DUP) rearrangements in cases 4 and 5, leading to complete F9 duplication and triplication, respectively. Conclusion Large deletions involving the F9 gene exhibit no apparent pattern, and the extra-hematologic clinical phenotypes require careful analysis of other genes within the deletion. The impact of complete F9 duplication and triplication on FIX expression might depend on the integrity of the F9 upstream sequence and the specific rearrangement mechanisms. Notably, DUP–TRP/INV–DUP rearrangements significantly elevate FIX activity and are closely associated with thrombotic phenotypes. Y.M. and Y.L. designed and performed the experiments and contributed to the writing of the manuscript. J.S., Q.L., and R.W., collected and organized the clinical cases. Q.D. and J.D. analyzed the data, reviewed and revised the manuscript, and provided supervision for the entire project. * These authors contributed equally as co-first authors. Received: 08 September 2023 Accepted: 21 November 2023 Accepted Manuscript online: 27 November 2023 Article published online: 26 December 2023 © 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 3 October 2023
- Published by Springer Nature in Thrombosis Journal
- Vol. 21 (1) , 1-10
Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study
Background: R189W and K193del of protein C (PC) were hotspot mutations in Chinese population with venous thromboembolism (VTE), but almost two-thirds of patients with above mutations coexisting with other genetically or aquiredly prothrombotic risk factors. The aim of this study is to clarify the independent contributions of R189W or K193del to VTE risk. Methods: 490 unrelated patients with a personal history of VTE and 410 healthy participants were enrolled in this study. Data of their demographics, family history, genetic and acquired thrombosis risk factors were collected and statistically analyzed. Results: PC R189W and K193del were identified in 3/410 (0.7%) and 7/410 (1.7%) healthy controls, and in 27/490 (5.5%) and 43/490 (8.8%) patients with VTE, respectively. Notably, about 70% of these mutant carriers combined with other genetic or acquired thrombophilic factors. After adjustment for age, gender, other inherited and acquired risk factors, we demonstrated that R189W and K193del were associated with 5.781-fold and 4.365-fold increased risk of VTE, respectively, which were significantly lower than the prothrombotic risk of anticoagulant deficiencies induced from rare mutations. Independent R189W or K193del mutation was not associated with earlier first-onset age as well as higher recurrent rate of VTE. However, combination of other genetic or acquired thrombophilic factors had supra-additive effects on those consequences. The more additional risk factors the patients had, the younger first-onset ages and higher risk of recurrence would be. Conclusions: As the most frequent mutations for PC deficiency in Chinese population, both R189W and K193del mutations had limited independent contributions to VTE development compared with other rare mutations in PROC gene, but may act in concert with other genetic defects or acquired thrombotic risk factors to produce the final severe phenotype.
- 3 October 2023
- Published by Springer Nature in Thrombosis Journal
- Vol. 21 (1) , 1-10
Open AccessEvaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study
Background: R189W and K193del of protein C (PC) were hotspot mutations in Chinese population with venous thromboembolism (VTE), but almost two-thirds of patients with above mutations coexisting with other genetically or aquiredly prothrombotic risk factors. The aim of this study is to clarify the independent contributions of R189W or K193del to VTE risk. Methods: 490 unrelated patients with a personal history of VTE and 410 healthy participants were enrolled in this study. Data of their demographics, family history, genetic and acquired thrombosis risk factors were collected and statistically analyzed. Results: PC R189W and K193del were identified in 3/410 (0.7%) and 7/410 (1.7%) healthy controls, and in 27/490 (5.5%) and 43/490 (8.8%) patients with VTE, respectively. Notably, about 70% of these mutant carriers combined with other genetic or acquired thrombophilic factors. After adjustment for age, gender, other inherited and acquired risk factors, we demonstrated that R189W and K193del were associated with 5.781-fold and 4.365-fold increased risk of VTE, respectively, which were significantly lower than the prothrombotic risk of anticoagulant deficiencies induced from rare mutations. Independent R189W or K193del mutation was not associated with earlier first-onset age as well as higher recurrent rate of VTE. However, combination of other genetic or acquired thrombophilic factors had supra-additive effects on those consequences. The more additional risk factors the patients had, the younger first-onset ages and higher risk of recurrence would be. Conclusions: As the most frequent mutations for PC deficiency in Chinese population, both R189W and K193del mutations had limited independent contributions to VTE development compared with other rare mutations in PROC gene, but may act in concert with other genetic defects or acquired thrombotic risk factors to produce the final severe phenotype.
- 14 July 2022
- Published by Elsevier in Thrombosis Research
- Vol. 217, 36-47
Congenital (hypo-)dysfibrinogenemia and bleeding: A systematic literature review
- 14 July 2022
- Published by Elsevier in Thrombosis Research
- Vol. 217, 36-47
Congenital (hypo-)dysfibrinogenemia and bleeding: A systematic literature review
- 26 September 2019
- Published by American Society of Hematology in Blood
- Vol. 134 (20) , 1745-1754
Low factor V level ameliorates bleeding diathesis in patients with combined deficiency of factor V and factor VIII
Combined FV and FVIII deficiency (F5F8D) is a rare autosomal recessive bleeding disorder caused by mutations in LMAN1 and MCFD2. Six different causative homozygous mutations (five in LMAN1 and one in MCFD2) were identified in 6 patients with F5F8D. Thrombin generation assay, triggered with 1 pM TF in F5F8D plasma, paradoxically exhibited enhanced thrombin generation compared to normal plasma. A significantly lower free tissue factor pathway inhibitor (fTFPI) was found in F5F8D patients compared to healthy controls (P<0.01). Normalizing TFPIα in F5F8D plasma greatly delayed and reduced thrombin generation. Increasing FV concentrations by adding plasma FV in F5F8D plasma only caused a gradual decrease of thrombin generation, suggesting that low levels of both TFPIα and FV co-contributed to the elevated thrombin generation by reducing their anticoagulant effects. On the contrary, thrombin generation in F5F8D platelet rich plasma (PRP) was significantly lower than in normal controls (P<0.05), but was fully corrected by either normalizing FVIII or after DDAVP infusion, indicating that the hypocoagulable state of F5F8D patients is associated with low FVIII levels. In addition, plasma and platelet FV in F5F8D PRP was sufficient to support normal thrombin generation and low TFPIα may have no effect on thrombin generation. The DDAVP infusion induced a complete response in five F5F8D patients and a partial response in the remaining one. Based on our findings, we suggest that DDAVP may be considered as a potential substitute for FVIII concentrates and FFP infusion may not be necessary for F5F8D patients with minor bleeding challenges. Key Points Low FV accompanied by a low fTFPI in F5F8D has optimal procoagulant activity, and addition of FV to plasma only results in anticoagulation. The use of DDAVP as a potential substitute for FVIII concentrates without FFP infusion is suggested in F5F8D patients with minor bleeding.
- 26 September 2019
- Published by American Society of Hematology in Blood
- Vol. 134 (20) , 1745-1754
Low factor V level ameliorates bleeding diathesis in patients with combined deficiency of factor V and factor VIII
Combined FV and FVIII deficiency (F5F8D) is a rare autosomal recessive bleeding disorder caused by mutations in LMAN1 and MCFD2. Six different causative homozygous mutations (five in LMAN1 and one in MCFD2) were identified in 6 patients with F5F8D. Thrombin generation assay, triggered with 1 pM TF in F5F8D plasma, paradoxically exhibited enhanced thrombin generation compared to normal plasma. A significantly lower free tissue factor pathway inhibitor (fTFPI) was found in F5F8D patients compared to healthy controls (P<0.01). Normalizing TFPIα in F5F8D plasma greatly delayed and reduced thrombin generation. Increasing FV concentrations by adding plasma FV in F5F8D plasma only caused a gradual decrease of thrombin generation, suggesting that low levels of both TFPIα and FV co-contributed to the elevated thrombin generation by reducing their anticoagulant effects. On the contrary, thrombin generation in F5F8D platelet rich plasma (PRP) was significantly lower than in normal controls (P<0.05), but was fully corrected by either normalizing FVIII or after DDAVP infusion, indicating that the hypocoagulable state of F5F8D patients is associated with low FVIII levels. In addition, plasma and platelet FV in F5F8D PRP was sufficient to support normal thrombin generation and low TFPIα may have no effect on thrombin generation. The DDAVP infusion induced a complete response in five F5F8D patients and a partial response in the remaining one. Based on our findings, we suggest that DDAVP may be considered as a potential substitute for FVIII concentrates and FFP infusion may not be necessary for F5F8D patients with minor bleeding challenges. Key Points Low FV accompanied by a low fTFPI in F5F8D has optimal procoagulant activity, and addition of FV to plasma only results in anticoagulation. The use of DDAVP as a potential substitute for FVIII concentrates without FFP infusion is suggested in F5F8D patients with minor bleeding.
- 30 January 2018
- Published by Wiley in Haemophilia
- Vol. 24 (2) , 291-298
Spectrum and origin of mutations in sporadic cases of haemophilia A in China
Introduction: About 30% of haemophilia A (HA) patients are sporadic cases. It is important to confirm the mutation origin and carrier status in these families.Aim: To describe the spectrum and origin of the mutations in 393 Chinese sporadic HA families and identify potential mosaics among non‐carrier mothers.Methods: AccuCopy quantification combined with long‐distance PCR was used for genotyping intron 22/1 inversion (Inv22/Inv1) and Inv22 mosaicism. F8 gene sequences were analysed by direct sequencing. Copy number variations of F8 gene were detected by AccuCopy method. Six short tandem repeats related to F8 gene were applied for linkage analysis. Mosaicism of point mutations/small deletions/insertions was determined by ddNTP primer extension method.Results: Most of sporadic patients’ mothers are carriers, in 257 cases with integral family members, 60% have the mutations tracing back to their fathers, 12% to their mothers. 28% had de novo mutations with non‐carrier mothers as revealed by routine genetic studies. Mutation spectrum of sporadic families was different in groups with different origins of mutations. Point mutation (51%) was the predominant mutation type in pedigrees with de novo mutations. While, in families with mutations inherited from maternal grandfathers, Inv22 was the main type (51%). We found somatic mosaic in mothers of 30% (3/10) pedigrees with de novo Inv22 and 11.5% (3/26) pedigrees with point mutations.Conclusion: The spectrum of F8 genetic variants identified in sporadic families was fairly diverse. The high prevalence of chimaeras in carriers suggests that more cautions should be taken in genetic counselling of sporadic haemophilia families.
- 30 January 2018
- Published by Wiley in Haemophilia
- Vol. 24 (2) , 291-298
Spectrum and origin of mutations in sporadic cases of haemophilia A in China
Introduction: About 30% of haemophilia A (HA) patients are sporadic cases. It is important to confirm the mutation origin and carrier status in these families.Aim: To describe the spectrum and origin of the mutations in 393 Chinese sporadic HA families and identify potential mosaics among non‐carrier mothers.Methods: AccuCopy quantification combined with long‐distance PCR was used for genotyping intron 22/1 inversion (Inv22/Inv1) and Inv22 mosaicism. F8 gene sequences were analysed by direct sequencing. Copy number variations of F8 gene were detected by AccuCopy method. Six short tandem repeats related to F8 gene were applied for linkage analysis. Mosaicism of point mutations/small deletions/insertions was determined by ddNTP primer extension method.Results: Most of sporadic patients’ mothers are carriers, in 257 cases with integral family members, 60% have the mutations tracing back to their fathers, 12% to their mothers. 28% had de novo mutations with non‐carrier mothers as revealed by routine genetic studies. Mutation spectrum of sporadic families was different in groups with different origins of mutations. Point mutation (51%) was the predominant mutation type in pedigrees with de novo mutations. While, in families with mutations inherited from maternal grandfathers, Inv22 was the main type (51%). We found somatic mosaic in mothers of 30% (3/10) pedigrees with de novo Inv22 and 11.5% (3/26) pedigrees with point mutations.Conclusion: The spectrum of F8 genetic variants identified in sporadic families was fairly diverse. The high prevalence of chimaeras in carriers suggests that more cautions should be taken in genetic counselling of sporadic haemophilia families.
- 1 August 2017
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 117 (08) , 1478-1485
Complex recombination with deletion in the F8 and duplication in the TMLHE mediated by int22h copies during early embryogenesis
Haemophilia A (HA) is a common X-linked recessive bleeding disorder and almost one half of patients with severe HA are caused by intron 22 inversion (Inv22) in the F8. Inv22 is considered to be almost exclusively of meiotic origin in germ cells during spermatogenesis and only one mosaic Inv22 female carrier with the mutation possibly occurring during mitosis of the embryo has been reported so far. Previously we have identified a novel complex recombination mediated by int22h copies in a sporadic severe HA pedigree and herein we have localised the sequences flanking the breakpoint region using genome walking technique, AccuCopy technique, gene chip and real-time PCR. The disease causing genetic variant registered an 18.1 kb deletion including part of int22h-1 through the intron 23 of F8 and a 113.3 kb duplication of part of int22h-2 through the intron 1 of TMLHE inserted in the religated region of the F8. Two intrinsically linked mechanisms of recombination-dependent DNA replication: microhomology-mediated break-induced replication (MMBIR) followed by break-induced replication (BIR) might be responsible for the incident of the complex recombination during early embryogenesis of the proband’s mother. Supplementary Material to this article is available online at www.thrombosis-online.com.
- 1 August 2017
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 117 (08) , 1478-1485
Complex recombination with deletion in the F8 and duplication in the TMLHE mediated by int22h copies during early embryogenesis
Haemophilia A (HA) is a common X-linked recessive bleeding disorder and almost one half of patients with severe HA are caused by intron 22 inversion (Inv22) in the F8. Inv22 is considered to be almost exclusively of meiotic origin in germ cells during spermatogenesis and only one mosaic Inv22 female carrier with the mutation possibly occurring during mitosis of the embryo has been reported so far. Previously we have identified a novel complex recombination mediated by int22h copies in a sporadic severe HA pedigree and herein we have localised the sequences flanking the breakpoint region using genome walking technique, AccuCopy technique, gene chip and real-time PCR. The disease causing genetic variant registered an 18.1 kb deletion including part of int22h-1 through the intron 23 of F8 and a 113.3 kb duplication of part of int22h-2 through the intron 1 of TMLHE inserted in the religated region of the F8. Two intrinsically linked mechanisms of recombination-dependent DNA replication: microhomology-mediated break-induced replication (MMBIR) followed by break-induced replication (BIR) might be responsible for the incident of the complex recombination during early embryogenesis of the proband’s mother. Supplementary Material to this article is available online at www.thrombosis-online.com.